Biomedical Product Development: From Biotech to Boardroom to Market
RGA6217 / 4 q.h.
Begins by recognizing that significant differences exist between small and mid-to-large medical device and pharmaceutical companies with regard to key variables in the current business environment. These differences extend to the opportunities available as well as the limitations and challenges faced by each. This course examines the evolution of the medical device and pharmaceutical landscape from a technological, regulatory, and financial perspective, as well as from a societal and cultural framework. Also examines the symbiotic and potentially synergistic relationship that has developed between small, yet established, biotechnology companies and large medical device and pharmaceutical firms, as well as the impact of these relationships on the general economic environment.
|
